Willingness to Pay for a COVID-19 Vaccine
- PMID: 33619688
- PMCID: PMC7899739
- DOI: 10.1007/s40258-021-00644-6
Willingness to Pay for a COVID-19 Vaccine
Abstract
Background: The coronavirus disease (COVID-19) pandemic has considerably affected the lives of people worldwide, impacting their health and economic welfare, and changing the behavior of our society significantly. This situation may lead to a strong incentive for people to buy a vaccine. Therefore, a relevant study to assess individuals' choices and the value of change in welfare from a COVID-19 vaccine is essential.
Objective: This study aimed to estimate the willingness-to-pay (WTP) value for a vaccine for COVID-19. We also identify the variables that influence individual vaccination decisions, which could be used in the design of vaccination promotion strategies.
Methods: We use the contingent valuation method in its double-bounded dichotomous choice format. The estimation coefficients are calculated according to the maximum likelihood method under the assumption of a probit distribution. The sample consisted of 531 individuals, mainly from middle- and high-income socioeconomic groups from Chile between enrolled between 10 July and 10 August 2020.
Results: The results show a high WTP for the COVID-19 vaccine, with a value up to US$232. Income and education levels and having family members with COVID-19 increased the likelihood of persons paying for a vaccine. There is also a greater fear as the pandemic progresses that people will get sick from COVID-19.
Conclusions: The high WTP value creates an opportunity for formulating public health policy. The results of this study suggest that governments can provide the vaccine free to low-income groups and allow those with higher incomes to acquire the vaccine through the private sector by paying. This will be useful especially for countries with economic difficulties.
Conflict of interest statement
The authors declare that there no conflicts of interest that are relevant to the contents of this article.
Figures


Comment in
-
Comment on: "Willingness to Pay for a COVID-19 Vaccine".Appl Health Econ Health Policy. 2021 Jul;19(4):619-621. doi: 10.1007/s40258-021-00656-2. Epub 2021 May 11. Appl Health Econ Health Policy. 2021. PMID: 33973148 Free PMC article. No abstract available.
Similar articles
-
Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia.Hum Vaccin Immunother. 2020 Dec 1;16(12):3074-3080. doi: 10.1080/21645515.2020.1819741. Epub 2020 Sep 29. Hum Vaccin Immunother. 2020. PMID: 32991230 Free PMC article.
-
Willingness to pay and financing preferences for COVID-19 vaccination in China.Vaccine. 2021 Apr 1;39(14):1968-1976. doi: 10.1016/j.vaccine.2021.02.060. Epub 2021 Feb 27. Vaccine. 2021. PMID: 33714653 Free PMC article.
-
The demand for a COVID-19 vaccine in Ecuador.Vaccine. 2020 Dec 3;38(51):8090-8098. doi: 10.1016/j.vaccine.2020.11.013. Epub 2020 Nov 6. Vaccine. 2020. PMID: 33187765 Free PMC article.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.J Integr Med. 2022 Jan;20(1):34-44. doi: 10.1016/j.joim.2021.10.004. Epub 2021 Oct 26. J Integr Med. 2022. PMID: 34774463 Free PMC article. Review.
Cited by
-
Sociodemographic Determinants of Willingness and Extent to Pay for COVID-19 Vaccine in India.Front Public Health. 2022 Jun 6;10:870880. doi: 10.3389/fpubh.2022.870880. eCollection 2022. Front Public Health. 2022. PMID: 35734756 Free PMC article.
-
The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: "Vaccination Refusal Could Prolong the War of This Pandemic" - A Systematic Review.Risk Manag Healthc Policy. 2021 Jun 21;14:2609-2623. doi: 10.2147/RMHP.S311074. eCollection 2021. Risk Manag Healthc Policy. 2021. PMID: 34188572 Free PMC article. Review.
-
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies.Eur J Health Econ. 2022 Dec;23(9):1455-1482. doi: 10.1007/s10198-022-01437-x. Epub 2022 Feb 15. Eur J Health Econ. 2022. PMID: 35166973 Free PMC article.
-
The Willingness to Pay for a Hypothetical Vaccine for the Coronavirus Disease 2019 (COVID-19).Int J Environ Res Public Health. 2021 Nov 26;18(23):12450. doi: 10.3390/ijerph182312450. Int J Environ Res Public Health. 2021. PMID: 34886179 Free PMC article.
-
Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: A cross-sectional study.Narra J. 2022 Apr;2(1):e74. doi: 10.52225/narra.v2i1.74. Epub 2022 Apr 1. Narra J. 2022. PMID: 38450393 Free PMC article.
References
-
- Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: a global health emergency. Sci Total Environ. 2020;730:138996. doi: 10.1016/j.scitotenv.2020.138996. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical